SBA 504 Interest Rates and Fees

The SBA 504 loan program uses a unique rate-setting mechanism that differs from virtually every other commercial financing product. Rather than a lender quoting a rate based on creditworthiness and market conditions, the CDC (Certified Development Company) portion of a 504 loan carries a rate determined through a monthly debenture sale conducted by the SBA.

Each month, the SBA pools approved 504 loans from CDCs nationwide into debentures, which are then sold to investors on the open market. The interest rate on these debentures is established at the time of sale based on current U.S. Treasury bond yields plus a spread. For 20-year debentures, the rate is benchmarked against the 10-year Treasury note yield. For 25-year debentures (available for certain real estate projects), the benchmark shifts to longer-duration Treasury securities.

This structure means that 504 rates are not negotiable between borrower and lender. The rate is set by market forces at the debenture sale, which typically occurs on the first Wednesday of each month. The borrower locks in the rate at the time of the sale that corresponds to their loan closing, not at application or approval.

Because these debentures carry an implicit government guarantee, they trade at favorable spreads compared to conventional commercial mortgage-backed securities. This is the mechanism that allows 504 loans to consistently offer fixed interest rates below what most conventional commercial lenders can match. The effective rate to the borrower includes the debenture coupon rate plus annual fees that cover the CDC's servicing costs and the SBA's guarantee fee, but even with these additions, the all-in rate typically remains competitive.

The rate a borrower pays on the CDC portion of an SBA 504 loan is not simply the debenture coupon rate. Several fee layers are added to the base rate to arrive at the effective rate the borrower actually pays over the life of the loan.

The base debenture rate reflects the yield investors require to purchase SBA-guaranteed debentures at the monthly sale. As of recent sales, 20-year debenture effective rates have generally ranged from approximately 5.5% to 7.0%, depending on Treasury market conditions at the time of sale. The 25-year debenture rates typically run slightly higher due to the longer duration risk.

On top of the base debenture coupon, the borrower's effective rate includes an annual SBA guarantee fee of approximately 0.3841% and a CDC servicing fee of approximately 0.625% per year. These fees are bundled into the monthly payment rather than billed separately, which means the borrower sees a single payment amount that reflects the total effective rate.

The combined effective rate (debenture coupon plus annual fees) is fixed for the entire loan term, whether 10, 20, or 25 years. This is a significant structural advantage compared to conventional commercial loans, which frequently reset rates every 5 to 7 years even on longer amortization schedules. Borrowers who want to understand how this compares to adjustable-rate alternatives should review how fixed versus variable rate structures affect long-term cost of capital.

One additional nuance: the SBA publishes effective rates after each monthly debenture sale, and CDCs can provide estimated rates in advance based on current Treasury yields. However, the exact rate is not confirmed until the sale closes, which introduces a brief window of rate uncertainty for borrowers whose loans are in the pipeline.

Beyond the ongoing interest rate, SBA 504 loans involve several upfront fees that borrowers need to factor into total project cost. These fees are charged by the SBA, the CDC, and the conventional lender (first mortgage holder), and they can add meaningfully to the initial capital required.

The SBA charges a guarantee fee at closing equal to approximately 1.7% of the debenture amount. This fee can be financed into the loan rather than paid out of pocket, which most borrowers elect to do. However, financing the fee increases the total loan balance and therefore the monthly payment.

The CDC charges a processing fee, typically around 1.5% of the CDC loan amount, which covers underwriting, legal, and administrative costs associated with packaging the loan for the debenture sale. Some CDCs may charge slightly more or less depending on the complexity of the project and regional market practices.

Additional closing costs commonly include an appraisal fee (typically $3,000 to $6,000 for Commercial Real Estate ), environmental review fees (Phase I environmental site assessments typically run $2,000 to $4,000 ), title insurance, survey costs, and legal fees. These third-party costs are not unique to 504 loans but are standard for any Commercial Real Estate transaction.

The conventional lender (providing the first mortgage, typically 50% of project cost) will charge its own origination fees, which commonly range from 0.5% to 1.0% of their loan amount. The conventional lender's fees are separate from the CDC/SBA fees and are negotiated directly between the borrower and the bank or credit union.

When evaluating total closing costs, borrowers should request a detailed fee breakdown from both the CDC and the conventional lender. Comparing loan offers across different CDCs and first-mortgage lenders can reveal meaningful differences in total upfront cost, even though the debenture rate itself is standardized.

The SBA 504 program structures every project as a split between a conventional first mortgage (typically 50% of project cost), the CDC/SBA second mortgage (up to 40%), and the borrower's equity injection (minimum 10%). The rate and terms on the conventional lender's first mortgage are entirely separate from the CDC debenture rate and are negotiated directly between borrower and lender.

Because the conventional lender's exposure is limited to 50% of the project value (rather than the 75-80% loan-to-value typical of a standalone commercial mortgage), the lender faces significantly less risk. This reduced risk position generally translates to more favorable rate and term offerings compared to what the same lender would quote on a standalone deal. Many borrowers find that the conventional lender portion carries rates 25 to 75 basis points below what they would pay on a standard commercial mortgage for the same property.

The conventional lender's portion may carry a fixed or variable rate, depending on the lender's products and the borrower's preference. The term on this portion varies as well. While the CDC loan is fixed for 20 or 25 years, the conventional lender may offer a 10-year term with a 20 or 25-year amortization schedule, creating a balloon payment at maturity. This mismatch between the CDC and conventional portions is an important planning consideration.

Borrowers should also understand that they are managing two separate loan relationships. The CDC loan is serviced through the debenture structure with standardized terms. The conventional loan is serviced by the originating bank or credit union with its own payment schedule, covenant requirements, and renewal process. This dual-servicing arrangement is straightforward in practice but requires attention during the initial term sheet review to ensure both sets of terms are clearly understood.

Some conventional lenders specialize in SBA 504 first mortgages and offer particularly competitive rates because they understand the reduced risk profile. Working with a CDC that has strong relationships with these specialized lenders can improve the overall cost structure of the deal.

Evaluating an SBA 504 loan strictly on its debenture rate misses the full picture. The true comparison requires calculating total cost of capital across the entire project, including both loan portions, all fees, and the time value of the fixed-rate lock over the full term.

Consider a $2 million Commercial Real Estate project. Under a standard 504 structure, the conventional lender provides $1 million (50%), the CDC provides $800,000 (40%), and the borrower injects $200,000 (10%). The borrower pays two different rates on two different loan portions, plus upfront fees on both. A standalone conventional mortgage on the same property might carry a single rate but require a 20-25% down payment ($400,000 to $500,000), effectively doubling the equity requirement.

The 504 structure's lower equity requirement frees up $200,000 to $300,000 in capital that the borrower can deploy into equipment, working capital, or other growth investments. This opportunity cost of capital is often the most significant financial advantage of the 504 program, exceeding the interest rate savings in many scenarios.

Over a 20-year term, the fixed-rate lock on the CDC portion also provides meaningful protection against rising interest rates. A conventional commercial mortgage that resets every 5 to 7 years exposes the borrower to rate risk at each renewal. If rates increase by 200 basis points over the first decade, the conventional borrower's payments increase substantially at renewal, while the 504 borrower's CDC portion remains unchanged.

The total cost comparison should account for: (1) the blended effective rate across both loan portions, (2) all upfront fees including SBA guarantee fee, CDC processing fee, and conventional lender origination, (3) the equity injection savings and the return those freed funds could generate, (4) rate risk over the full term compared to conventional alternatives with periodic resets, and (5) any prepayment considerations if early payoff is possible. Running this full analysis typically reveals that 504 financing delivers a lower total cost of capital for projects that fit the program's requirements, particularly for owner-occupied Commercial Real Estate and major equipment purchases with useful lives of 10 years or more.

Because SBA 504 debenture rates are set at a specific monthly sale rather than locked at application, borrowers face a timing consideration that does not exist with most conventional loans. Understanding the rate-setting timeline helps borrowers plan their project schedule to minimize rate uncertainty.

The typical 504 loan timeline from application to funding runs 60 to 90 days, though complex projects can take longer. The loan must be fully approved and closed before it can be included in a monthly debenture sale. If a loan closes just after one monthly sale, it will be pooled into the following month's sale, potentially adding 3 to 4 weeks of rate exposure.

CDCs track the debenture sale calendar closely and can advise borrowers on timing. Some borrowers choose to accelerate or delay their closing by a few days to target a specific monthly sale, particularly if Treasury yields are trending favorably or unfavorably. This timing strategy carries some risk, as rate movements between monthly sales can move effective rates by 10 to 30 basis points in either direction.

Unlike conventional loans where borrowers can often pay a fee to lock a rate for 30 to 60 days, the 504 debenture rate cannot be locked in advance. The rate is determined solely by market conditions at the time of the monthly sale. This means borrowers should build a rate cushion into their financial projections rather than planning around a specific target rate.

For borrowers concerned about rate risk during the processing period, one practical approach is to model the project at a rate 50 basis points above current effective rates. If the project still meets cash flow and return requirements at that higher rate, the borrower can proceed with confidence regardless of short-term rate movements. This conservative underwriting approach aligns with sound loan offer evaluation practices and avoids the trap of building a business case around a rate that may not materialize.

Experienced CDCs publish rate trend reports and provide regular updates to borrowers in the pipeline, helping them anticipate the effective rate before the sale date. While this is not a guarantee, it gives borrowers reasonable visibility into their likely all-in cost as the closing date approaches.